TGFB1 and colorectal carcinoma: The combined HR of the 7 studies that evaluated the relationship of the high expression of TGF-β to DFS was 1.11 (95% CI: 1.03–1.19, Table 3, Fig. 4), which suggests that high expression of TGF-β is a significant prognostic factor for CRC patients.